Developing vaccines for better immunity against viruses.
CIVIC SARS-CoV-2 Research Activities
['FUNDING_OTHER'] · DUKE UNIVERSITY · NIH-10697230
This study is looking for ways to make new vaccines that help your body fight off viruses like COVID-19, and it will involve patients testing how well these vaccines work and how to give them in the best way possible.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DUKE UNIVERSITY (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-10697230 on ClinicalTrials.gov |
What this research studies
This research focuses on creating and testing new vaccine candidates and delivery methods to provide strong and lasting immunity against various viruses, including SARS-CoV-2. The approach involves innovative designs that aim to enhance the body's immune response. Patients may be involved in trials that evaluate how well these new vaccines work in generating protection against infections. The research seeks to understand the best ways to deliver these vaccines to maximize their effectiveness.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who are at risk of COVID-19 or other viral infections and are interested in contributing to vaccine development.
Not a fit: Patients who are not at risk for viral infections or those who have already received effective vaccines may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that provide long-lasting immunity against COVID-19 and potentially other viral infections.
How similar studies have performed: Other research has shown promise in developing innovative vaccine approaches, indicating potential for success in this area.
Where this research is happening
DURHAM, UNITED STATES
- DUKE UNIVERSITY — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MOODY, TONY — DUKE UNIVERSITY
- Study coordinator: MOODY, TONY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.